Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
LEMAITRE VASCULAR INC (LMAT)
|
Add to portfolio |
|
|
|
| Price: |
$51.50
| | Metrics |
| OS: |
22.3
|
M
| |
9
|
% ROE
|
| Market cap: |
$1.15
|
B
| |
14
|
% ROIC
|
|
Net cash:
|
$90.2
|
M
| |
$4.05
|
per share
|
|
EV:
|
$1.06
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$39.9
|
M
| |
26.5
|
x EV/EBITDA
|
|
EBIT
|
$30.6
|
M
| |
34.5
|
x EV/EBIT
|
| EPS |
$1.13
| |
45.5
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 161.7 | 154.4 | 129.4 | 117.2 | 105.6 | 100.9 | 89.2 | 78.4 |
| Revenue growth | 4.7% | 19.4% | 10.4% | 11.0% | 4.7% | 13.1% | 13.8% | 10.2% |
| Cost of goods sold | 56.8 | 53.0 | 44.7 | 37.4 | 31.6 | 30.2 | 26.2 | 24.2 |
| Gross profit | 104.9 | 101.4 | 84.6 | 79.9 | 73.9 | 70.7 | 62.9 | 54.2 |
| Gross margin | 64.9% | 65.7% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% | 69.1% |
| Sales and marketing | 32.9 | 27.7 | 23.7 | 30.3 | 27.3 | 25.9 | 26.1 | 22.8 |
| Research and development | 13.3 | 11.8 | 10.1 | 9.3 | 8.2 | 6.6 | 6.1 | 5.5 |
| General and administrative | 28.7 | 25.5 | 22.5 | 19.1 | 17.7 | 17.0 | 14.4 | 14.0 |
| EBITA | 33.2 | 43.4 | 33.3 | 23.6 | 30.0 | 22.8 | 18.0 | 12.7 |
| EBITA margin | 20.5% | 28.1% | 25.7% | 20.1% | 28.4% | 22.6% | 20.2% | 16.2% |
| Amortization of intangibles | 6.2 | 6.2 | 5.0 | 2.4 | 1.8 | 1.8 | 1.6 | 1.5 |
| EBIT | 27.0 | 37.2 | 28.2 | 21.2 | 28.2 | 21.0 | 16.4 | 11.2 |
| EBIT margin | 16.7% | 24.1% | 21.8% | 18.1% | 26.7% | 20.8% | 18.4% | 14.2% |
| Pre-tax income | 27.5 | 34.3 | 27.4 | 21.7 | 28.4 | 21.1 | 16.2 | 11.4 |
| Income taxes | 6.9 | 7.4 | 6.1 | 3.7 | 5.5 | 3.9 | 5.7 | 3.7 |
| Tax rate | 24.9% | 21.5% | 22.4% | 17.3% | 19.3% | 18.6% | 34.8% | 32.1% |
| Net income | 20.6 | 26.9 | 21.2 | 17.9 | 22.9 | 17.2 | 10.6 | 7.8 |
| Net margin | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% | 9.9% |
| |
| Diluted EPS | $0.93 | $1.25 | $1.04 | $0.88 | $1.13 | $0.86 | $0.55 | $0.42 |
| Shares outstanding (diluted) | 22.2 | 21.5 | 20.5 | 20.3 | 20.2 | 20.0 | 19.2 | 18.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|